BT
Brendan Teehan (EVP, COO, HEAD OF COMMERCIAL) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $174K of ACAD (10,329 sh × $16.81, as filed), executed Nov 19 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 19 2024
Filed Nov 19 2024
Median ADV $49.5M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ACADRecent filings
ACADSALE
ACADIA Pharmaceuticals Inc.
View filing →
$174K10,329 sh × $16.81
Exec Nov 19 2024
Filed Nov 19 2024 · 5:30 PM ET